CO2021001057A2 - Composición y método para el ahorro de opioides - Google Patents

Composición y método para el ahorro de opioides

Info

Publication number
CO2021001057A2
CO2021001057A2 CONC2021/0001057A CO2021001057A CO2021001057A2 CO 2021001057 A2 CO2021001057 A2 CO 2021001057A2 CO 2021001057 A CO2021001057 A CO 2021001057A CO 2021001057 A2 CO2021001057 A2 CO 2021001057A2
Authority
CO
Colombia
Prior art keywords
composition
opioid sparing
relates
opioid
sparing
Prior art date
Application number
CONC2021/0001057A
Other languages
English (en)
Inventor
Harry Karelis
Original Assignee
Zelira Therapeutics Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zelira Therapeutics Operations Pty Ltd filed Critical Zelira Therapeutics Operations Pty Ltd
Publication of CO2021001057A2 publication Critical patent/CO2021001057A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La invención se relación con una composición farmacéutica que comprende Δ9-tetrahidrocannabinol (THC), cannabidiol (CBD) y una fracción de terpenos obtenida por extracción de una planta de Cannabis y su uso en el tratamiento de la dependencia y/o adicción a los opioides. La invención también se refiere a métodos para el ahorro de opioides.
CONC2021/0001057A 2018-07-03 2021-01-29 Composición y método para el ahorro de opioides CO2021001057A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2018100928A AU2018100928A4 (en) 2018-07-03 2018-07-03 Composition and method for opioid sparing
PCT/AU2019/050699 WO2020006598A1 (en) 2018-07-03 2019-07-03 Composition and method for opioid sparing

Publications (1)

Publication Number Publication Date
CO2021001057A2 true CO2021001057A2 (es) 2021-06-30

Family

ID=63079660

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2021/0001057A CO2021001057A2 (es) 2018-07-03 2021-01-29 Composición y método para el ahorro de opioides

Country Status (13)

Country Link
US (1) US20210290592A1 (es)
EP (1) EP3817734A4 (es)
KR (1) KR20210071941A (es)
AU (2) AU2018100928A4 (es)
BR (1) BR112020027070A2 (es)
CA (1) CA3104741A1 (es)
CL (1) CL2020003373A1 (es)
CO (1) CO2021001057A2 (es)
IL (1) IL279903A (es)
MX (1) MX2021000023A (es)
PE (1) PE20211586A1 (es)
SG (1) SG11202013194VA (es)
WO (1) WO2020006598A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020188361A1 (en) * 2019-03-21 2020-09-24 ZYUS Life Sciences US Ltd. Cannabinoid and application supported opioid tapering
CN115843248A (zh) * 2020-06-12 2023-03-24 泽利拉治疗手术私人有限公司 用于治疗慢性疼痛的组合物和方法
EP4362936A1 (en) * 2021-07-01 2024-05-08 Ananda Scientififc, Inc. Methods for treatment of pain with cannabinoids
CA3241130A1 (en) 2022-01-28 2023-08-03 Bastian BAASCH Method for the production of a plant extract
WO2023144420A1 (en) 2022-01-31 2023-08-03 Vertanical GmbH Composition comprising delta-9-tetrahydrocannabinol and terpenes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3209312A1 (en) * 2014-10-21 2017-08-30 United Cannabis Corp. Cannabis extracts and methods of preparing and using same
US20180000727A1 (en) * 2015-01-21 2018-01-04 Michael Willinsky Composition and methods to improve stability, dosing, pharmacodynamics and product shelf life of endocannabinoids, phytocannabinoids and synthetic cannabinoids delivered by nasal inhaer
WO2018222923A1 (en) * 2017-05-31 2018-12-06 Phytecs, Inc. Pharmaceutical compositions comprising cannabidiol and beta-caryophyllene and methods for their use
WO2019089558A1 (en) * 2017-10-30 2019-05-09 Endocanna Health, Inc. Graphical user interfaces for determining personalized endocannabinoid genotypes and associated recommendations

Also Published As

Publication number Publication date
AU2018100928A4 (en) 2018-08-09
PE20211586A1 (es) 2021-08-18
EP3817734A4 (en) 2022-03-16
BR112020027070A2 (pt) 2021-03-30
CA3104741A1 (en) 2020-01-09
WO2020006598A1 (en) 2020-01-09
AU2019297197A1 (en) 2021-01-28
US20210290592A1 (en) 2021-09-23
KR20210071941A (ko) 2021-06-16
MX2021000023A (es) 2021-05-27
CL2020003373A1 (es) 2021-08-13
EP3817734A1 (en) 2021-05-12
SG11202013194VA (en) 2021-01-28
IL279903A (en) 2021-03-01

Similar Documents

Publication Publication Date Title
CO2021001057A2 (es) Composición y método para el ahorro de opioides
CO2021001061A2 (es) Composición y método para tratar el dolor
CO2017004974A2 (es) Extractos de cannabis y métodos de preparación.
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
CL2020000025A1 (es) Componentes liberadores de constituyentes del tabaco.
MX2020001443A (es) Sistema y métodos de extracción fitoquímica para extraer fitoquímicos de plantas incluidas las plantas de la familia cannabaceae sensu stricto.
CO2019001043A2 (es) Composición de cannabis
MX2019003735A (es) Formulaciones diluibles de cannabinoides y procesos para su preparacion.
CO2017008437A2 (es) Métodos de purificación de cannabinoides, composiciones y kits de los mismos
IN2014DN09507A (es)
MX2019002198A (es) Composiciones solubles en agua que comprenden cannabinoides purificadas.
PE20200726A1 (es) Composicion de cannabis
AU2016261707A8 (en) Use of cannabis to treat fibromyalgia, methods and compositions thereof
CO2019000787A2 (es) Nuevas formulaciones y composiciones de cannabis en comprimidos y métodos para su elaboración
CO2021001059A2 (es) Composición de cannabinoides y método para tratar el ptsd y/o la ansiedad
PE20200338A1 (es) Composiciones cannabinoides novedosas y metodos para tratar la epilepsia infantil
BR112016017612A2 (pt) Uso de um extrato de uma planta do gênero mentha da família lamiaceae
CL2019000887A1 (es) Extracto de planta impregnado de alulosa y método de preparación para el mismo.
NI201700036A (es) Derivados estabilizados de adrenomedulina y uso de los mismos.
AR096260A1 (es) Inhibidor de la corrosión de henna para un ácido en un pozo
EA201991659A1 (ru) Композиция от кашля
CO2019000604A2 (es) Composición vaginal que comprende una combinación de estrógeno y vitamina d
BR112018007475A2 (pt) ?solvente de extração e/ou solubilização, método para extrair compostos biológicos naturais, usos do solvente de extração e/ou solubilização e do extrato, e, extrato biológico natural?
AR097111A1 (es) Combinación y método para la administración a un animal
CL2014003620A1 (es) Método de síntesis de nanopartículas de oro que comprende el uso de un extracto acuoso de la planta colliguaja salicifolia (colliguay o colihuai).